Research into the development of an early detection test for ovarian cancer at Griffith University’s Institute for Glycomics has been given a $300,000 funding boost from The Bourne Foundation and a further significant funding pledge from Tour de Cure. “Despite decades of research, there is currently no easily accessible, non-invasive and reliable early detection test […]
Strep A, which can lead to serious illness and death if untreated, should be recognised as a Neglected Tropical Disease according to a leading infectious disease expert. Professor Michael Good AO, Principal Research Leader at Griffith University’s Institute for Glycomics, authored a paper published this week in PLOS Neglected Tropical Diseases. Neglected tropical diseases (NTDs) […]
Researchers from the Institute for Glycomics and the University of Adelaide, have entered into an exclusive licensing deal with Sienna Cancer Diagnostics Ltd to commercialise a novel cancer diagnostic tool. Together, the teams of researchers have engineered a unique protein, called SubB2M, that binds specifically to a sugar molecule only present in cancer cells – a potential […]
Four teams of expert scientists from Griffith University’s Institute for Glycomics are targeting the virus SARS-CoV-2 to discover new vaccines and drugs to prevent or cure COVID-19. The teams are led by the Institute’s group leaders Professor Mark von Itzstein AO, Professor Michael Good AO, Professor Michael Jennings, and Professor Johnson Mak, all world-renowned research […]
MBA Lawyers, a long established and well-respected law firm based on the Gold Coast, has signed a memorandum of understanding to become a major corporate sponsor of the Malaria Vaccine Project. Established in March 2017, the Malaria Vaccine Project is a partnership between Rotary District 9640 and Griffith University’s Institute for Glycomics which aims to […]
Griffith’s Institute for Glycomics and Germany’s Bremen University have received funding to continue a research exchange to develop a drug delivery system to treat Non-Hodgkin’s Lymphoma.
Research done by Griffith University and the Hefei Institute of Material Science of the Chinese Academy of Sciences proposes that deep mutational scanning in combination with high throughput sequencing alone can be used to infer highly accurate structures for proteins and RNAs (Ribonucleic acids) without having to use expensive equipment. Understanding the structural clues behind […]